A pharmaceutical composition suitable for oral administration and a pretreatment method with an intestinal motility regulator and a-d-galagtosidase, as well as the use of the pharmaceutical composition in the prevention and treatment of irritable bowel syndrome
- 专利权人:
- LLP;POSI VISIONARY SOLUTIONS
- 发明人:
- BERNARDO ESCUDERO, ROBERTO,SAVOIR VILBOUEF, JOHN CLAUDE
- 申请号：
- MA36003
- 公开号：
- MA34730B1
- 申请日:
- 2013.06.10
- 申请国别(地区):
- MA
- 年份:
- 2013
- 代理人:
- 摘要：
- pharmaceutical composition adapted for oral administration and its method of preparation and modifying the intestinal motilit u00c9 and one of galagtosidase, use of the pharmaceutical composition for prevention and treatment of irritable bowel syndromeCOMPOSITION PHARMACEUTIQUE ADAPTÉE À L'ADMINISTRATION PAR VOIE ORALE ET SON PROCÉDÉ DE PRÉPARATION AVEC UN MODIFICATEUR DE LA MOTILITÉ INTESTINALE ET UNE A-D-GALAGTOSIDASE, UTILISATION DE LADITE COMPOSITION PHARMACEUTIQUE POUR LA PRÉVENTION ET LE TRAITEMENT DU SYNDROME DE L'INTESTIN IRRITABLE
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL COMPOSITION ADAPTED FOR ORAL ADMINISTRATION AND THE PROCESS FOR ITS PREPARATION, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, BASED ON AN INTESTINAL MOTILITY MODIFIER AND a-D-GALACTOSIDASE
- Pharmaceutical composition for oral Administration for the treatment of irritable bowel syndrome on the basis of a modifier of digestive Gut motility, an agent that prevents the Gas Retention and Digestive Enzyme and Process for its preparation
- ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER AND α-D-GALACTOSIDASE
- Orally administered Pharmaceutical composition adapted for and Process for its preparation, to Prevention and Treatment of irritable bowel syndrome on the basis of a modifier of intestinal motility and dgalactosidasa -
- Orally administered Pharmaceutical composition adapted for and Process for its preparation, to Prevention and Treatment of irritable bowel syndrome on the basis of a modifier of intestinal motility and - D - Galactosidase
